Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
JNNP 100
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
JNNP 100
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 86, Issue 2
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Multiple sclerosis
Research paper
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
Free
Online download statistics by month:
Online download statistics by month: May 2014 to March 2024
Abstract
Full
Pdf
May 2014
754
103
153
Jun 2014
323
103
115
Jul 2014
69
67
66
Aug 2014
74
34
43
Sep 2014
89
45
47
Oct 2014
532
66
92
Nov 2014
122
41
61
Dec 2014
114
50
50
Jan 2015
1107
248
188
Feb 2015
717
519
304
Mar 2015
424
350
204
Apr 2015
308
403
200
May 2015
199
409
130
Jun 2015
159
109
73
Jul 2015
138
72
69
Aug 2015
105
73
82
Sep 2015
110
72
70
Oct 2015
61
45
36
Nov 2015
93
112
72
Dec 2015
89
58
60
Jan 2016
122
75
69
Feb 2016
70
219
95
Mar 2016
93
73
68
Apr 2016
107
60
58
May 2016
88
97
57
Jun 2016
63
47
44
Jul 2016
63
40
39
Aug 2016
65
41
38
Sep 2016
101
48
43
Oct 2016
72
66
54
Nov 2016
46
58
58
Dec 2016
54
45
85
Jan 2017
68
68
52
Feb 2017
67
61
50
Mar 2017
49
50
29
Apr 2017
35
85
47
May 2017
28
92
53
Jun 2017
46
88
40
Jul 2017
127
71
52
Aug 2017
100
64
51
Sep 2017
154
80
35
Oct 2017
117
66
21
Nov 2017
172
83
38
Dec 2017
128
71
27
Jan 2018
168
83
26
Feb 2018
203
88
49
Mar 2018
186
89
46
Apr 2018
176
117
37
May 2018
213
161
32
Jun 2018
142
116
44
Jul 2018
111
103
36
Aug 2018
116
76
32
Sep 2018
138
45
36
Oct 2018
173
126
28
Nov 2018
126
118
39
Dec 2018
123
116
30
Jan 2019
145
133
33
Feb 2019
115
112
36
Mar 2019
109
101
47
Apr 2019
112
104
38
May 2019
77
72
34
Jun 2019
60
56
31
Jul 2019
76
42
27
Aug 2019
71
47
27
Sep 2019
85
46
25
Oct 2019
117
51
31
Nov 2019
82
52
33
Dec 2019
76
36
33
Jan 2020
84
38
32
Feb 2020
122
50
29
Mar 2020
97
70
26
Apr 2020
61
33
20
May 2020
65
51
19
Jun 2020
53
37
14
Jul 2020
57
41
12
Aug 2020
49
23
17
Sep 2020
54
30
22
Oct 2020
74
41
22
Nov 2020
82
43
28
Dec 2020
47
31
12
Jan 2021
56
38
31
Feb 2021
62
40
45
Mar 2021
72
42
36
Apr 2021
49
31
10
May 2021
41
30
15
Jun 2021
42
40
34
Jul 2021
65
63
21
Aug 2021
56
52
13
Sep 2021
63
60
49
Oct 2021
113
85
39
Nov 2021
86
66
27
Dec 2021
98
76
14
Jan 2022
133
97
39
Feb 2022
136
113
35
Mar 2022
130
111
25
Apr 2022
110
81
21
May 2022
140
101
25
Jun 2022
101
77
17
Jul 2022
159
127
26
Aug 2022
112
94
10
Sep 2022
161
108
18
Oct 2022
111
88
29
Nov 2022
130
106
13
Dec 2022
87
71
18
Jan 2023
147
129
20
Feb 2023
168
153
17
Mar 2023
140
110
16
Apr 2023
159
114
23
May 2023
139
117
31
Jun 2023
115
93
12
Jul 2023
100
84
10
Aug 2023
87
76
12
Sep 2023
140
84
15
Oct 2023
113
87
12
Nov 2023
192
170
30
Dec 2023
88
64
7
Jan 2024
109
103
22
Feb 2024
76
61
23
Mar 2024
68
48
80
Total
15621
10595
5341
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?